Literature DB >> 8302796

Lithostathine, an inhibitor of CaCO3 crystal growth in pancreatic juice, induces bacterial aggregation.

J Iovanna1, J M Frigerio, N Dusetti, F Ramare, P Raibaud, J C Dagorn.   

Abstract

Lithostathine is a pancreatic secretory protein which controls CaCO3 crystal growth in pancreatic juice. Trypsin hydrolysis of the molecule generates two fragments of 11 and 133 amino acids. The N-terminal undecapeptide bears the inhibitory activity for crystal growth. We demonstrate that the C-terminal part of the molecule, which is structurally related to Ca(2+)-dependent lectins, can induce bacterial aggregation. Ca(2+)- and pH-dependent aggregation was obtained for Escherichia coli strain KH 802 and 9 of 19 strains isolated from the predominant flora of human feces. Aggregation of E. coli could be reversed by dilution and bacteria could resume normal growth. Lithostathine is apparently the only component of normal pancreatic juice displaying such activity. Lithostathine is therefore a bifunctional protein which might be involved in the control of the bacterial ecosystem in the intestine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8302796     DOI: 10.1097/00006676-199309000-00011

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  15 in total

1.  Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation.

Authors:  J A Bertrand; D Pignol; J P Bernard; J M Verdier; J C Dagorn; J C Fontecilla-Camps
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Comparison of His and GST tagged versions of recombinant pancreatitis associated protein 2 in modulation of inflammatory responses.

Authors:  Domenico Viterbo; Michael E Zenilman; Martin H Bluth
Journal:  Inflamm Res       Date:  2010-04-16       Impact factor: 4.575

3.  Pure pancreatic juice from patients with chronic pancreatitis has an impaired antibacterial activity.

Authors:  F Marotta; H Tajiri; Z L Li; R Barreto; O Bellini; G Barbi
Journal:  Int J Pancreatol       Date:  1997-12

4.  Pancreatitis associated protein as an early marker of acute pancreatitis.

Authors:  E Kemppainen; J Sand; P Puolakkainen; S Laine; J Hedström; V Sainio; R Haapiainen; I Nordback
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

5.  Defining the Interaction of Human Soluble Lectin ZG16p and Mycobacterial Phosphatidylinositol Mannosides.

Authors:  Shinya Hanashima; Sebastian Götze; Yan Liu; Akemi Ikeda; Kyoko Kojima-Aikawa; Naoyuki Taniguchi; Daniel Varón Silva; Ten Feizi; Peter H Seeberger; Yoshiki Yamaguchi
Journal:  Chembiochem       Date:  2015-06-11       Impact factor: 3.164

6.  Immunocytochemical localization of pancreatitis-associated protein in human small intestine.

Authors:  L Masciotra; P Lechêne de la Porte; J M Frigerio; N J Dusetti; J C Dagorn; J L Iovanna
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

7.  REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum.

Authors:  L M P Loonen; E H Stolte; M T J Jaklofsky; M Meijerink; J Dekker; P van Baarlen; J M Wells
Journal:  Mucosal Immunol       Date:  2013-12-18       Impact factor: 7.313

8.  Regenerating proteins and their expression, regulation and signaling.

Authors:  Abhirath Parikh; Anne-Fleur Stephan; Emmanuel S Tzanakakis
Journal:  Biomol Concepts       Date:  2011-11-10

9.  Proteolytic activation of human pancreatitis-associated protein is required for peptidoglycan binding and bacterial aggregation.

Authors:  Péter Medveczky; Richárd Szmola; Miklós Sahin-Tóth
Journal:  Biochem J       Date:  2009-05-13       Impact factor: 3.857

10.  Proteomic View of Interactions of Shiga Toxin-Producing Escherichia coli with the Intestinal Environment in Gnotobiotic Piglets.

Authors:  Rembert Pieper; Quanshun Zhang; David J Clark; Prashanth P Parmar; Hamid Alami; Moo-Jin Suh; Srilatha Kuntumalla; John C Braisted; Shih-Ting Huang; Saul Tzipori
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.